Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tharimmune ( (THAR) ) has shared an update.
On September 5, 2025, Tharimmune, Inc. received confirmation from Nasdaq that it complies with Listing Rule 5550(b)(1) after reporting stockholders’ equity of $6,876,335 as of August 31, 2025. This compliance closes the matter with Nasdaq, potentially stabilizing the company’s market position and reassuring stakeholders.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 10,023,049
Technical Sentiment Signal: Buy
Current Market Cap: $23.53M
For detailed information about THAR stock, go to TipRanks’ Stock Analysis page.